Summary
Two cases of histologically proven primary cerebral malignant lymphoma were examined serially with positron emission tomography (PET) using11C-methyl-l-methionine (11C Met). Lesions delineated by11C Met accumulation extended beyond enhancing areas on either X-ray computed tomography (CT) or magnetic resonance imaging. High uptake of11C Met accurately showed biologically active and residual tumours, at a time when disappearance of a contrast-enhancing lesion on CT seemed to indicate involution. PET provides valuable information on the extent of tumour and assessment of radiotherapy in malignant lymphoma.
Similar content being viewed by others
References
Mineura K, Sasajima T, Suda Y, Kowada M, Shishido F, Uemura K (1989) Early and accurate detection of primary cerebral glioma with interfibrillary growth using11C-l-methionine positron emmission tomography. J Med Imaging 33:192–196
Derlon JM, Bourdet C, Bustany P, Chatel M, Theron J, Darcel F, Syrota A (1989) [11C]l-methionine uptake in gliomas. Neurosurgery 25:720–728
Erickson K, Lilja A, Bergstrom M, Collins P, Eriksson L, Ehrin E, Holst H von, Lundqvist H, Langstrom B, Mosskin M (1985) Positron emission tomography with ([11C]methyl)-l-methionine, [11C]d-glucose, and [68Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr 9:683–689
Hochberg FH, Millar DC (1988) Primary central nervous system lymphoma. J Neurosurg 68:835–853
Jiddane M, Nicoli F, Diaz P, Bergvall U, Vincentell F, Hassoun J, Salamon G (1986) Intracranial malignant lymphoma. J Neurosurg 65:592–599
Mendenhall NP, Thar TL, Agee OF, Harty-Golder B, Ballinger WE, Millon RR (1983) Primary lymphoma of the central nervous system: computerized tomography scan characteristics and treatment results for 12 cases. Cancer 52:1993–2000
Murray K, Kin L, Cox J (1986) Primary lymphoma of the central nervous system: results of treatment of 11 cases and review of the literature. J Neurosurg 65:600–607
Grant JW, Gallagher PJ, Jones DB (1986) Primary cerebral lymphoma: a histologic and immunohistochemical study of six cases. Arch Pathol Lab Med 110:897–901
Newell GR, Cabanillas FG, Hagemeister FJ, Butler JJ (1987) Incidence of lymphoma in the US classified by the Working Formulation. Cancer 59:857–861
Baumgartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy RM, Wara WM, Rosenblum ML (1990) Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 73:206–211
Leibel SA, Sheline GE (1987) Radiation therapy for neoplasms of the brain. J Neurosurg 66:1–22
Niibe H, Tamaki Y, Watanabe S, Masaki N, Horiuchi J, Hayabuchi N, Kaneda K, Morita K (1988) Therapeutic results of primary cerebral malignant lymphoma of the brain (in Japanese). Jpn J Cancer Clin 34:651–667
Kuwabara Y, Ichiya Y, Otsuka M, Miyake Y, Gunasekawa R, Hasuo K, Masuda K, Takeshita I, Fukui H (1988) High [18F]FDG uptake in primary cerebral lymphoma: a PET study. J Comput Assist Tomogr 12:47–48
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sawataishi, J., Mineura, K., Sasajima, T. et al. Effects of radiotherapy determined by11C-methyl-l-methionine positron emission tomography in patients with primary cerebral malignant lymphoma. Neuroradiology 34, 517–519 (1992). https://doi.org/10.1007/BF00598964
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00598964